1. Vogler S, Zimmermann N, De Joncheere K. The Pharmaceutical Pricing and Reimbursement Information (PPRI) network - a decade of exchange of information and policy research? J Pharm Policy Pract. 2015;8 Suppl 1, E4.
2. Vogler S, Zimmermann N, Ferrario A, Wirtz VJ. Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. J Pharm Policy Pract. 2015;8(1), E1.
3. Vogler S, Zimmermann N, Wirtz V, Babar Z-U-D. Policies beyond the crisis: lesson learned. J Pharm Policy Pract. 2015;8 Suppl 1, E2.
4. Vogler S, Zimmermann N, Wirtz V, Babar Z-U-D. Policy cooperation and interface issues. J Pharm Policy Pract. 2015;8 Suppl 1, E3.
5. World Health Organization. The selection and use of essential medicines. Report of the WHO Expert Committee, 2015 (including the 19th WHO Model List of Essential Medicines and the 5th WHO Model List of Essential Medicines for Children. WHO Technical Report Series. Geneva 2015. http://apps.who.int/iris/bitstream/10665/189763/1/9789241209946_eng.pdf?ua=1 (accessed 3 February 2016).